The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Last year, the U.S. Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 pounds or more, and this month it approved a lower dose spray for ...

A recent study led by Mass General Brigham researchers found that a nasal spray developed to target inflammation in the brain could be used to treat chronic symptoms of traumatic brain injury.

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

A woman has told how she was left in hospital "unable to breathe" after suffering a severe reaction to an unlicensed nasal tanning spray she bought online. Edith Eagle said she felt like she was ...

But prizes weren’t always relegated to children. In 1905, Quaker Oats awarded consumers free bowls of fine China in exchange for box tokens. Obviously, Quaker wasn’t stuffing fragile ...

To find the best automatic litter boxes worth investing in (and yes, they are an investment), I enlisted my three favorite felines to put seven top contenders to the test. In our collective ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that International Medication Systems, Ltd. ("IMS"), a subsidiary of ...